AK112 and AK104 With or Without Chemotherapy in Advanced Non-small Cell Lung Cancer

NCT05904379 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

233

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Non-small-cell Lung Cancer

Interventions

DRUG: AK112
DRUG: AK104
DRUG: Carboplatin
DRUG: paclitaxel
DRUG: pemetrexed
DRUG: Docetaxel

Sponsor

Akeso